title: Absence of transaminase elevation during concomitant methotrexate and isoniazid therapy.
authors.forename: Lea Hilda
authors.initials: LH
authors.lastname: Ekochin
authors.forename: Augustine M
authors.initials: AM
authors.lastname: Manadan
authors.forename: Rohit
authors.initials: R
authors.lastname: Aggarwal
authors.forename: Winston
authors.initials: W
authors.lastname: Sequeira
authors.forename: Joel A
authors.initials: JA
authors.lastname: Block
mesh_terms: D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D012189:Retrospective Studies; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy*; D000637:Transaminases / Q000378:metabolism*; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*
chemical_list: D018501:Antirheumatic Agents; D000995:Antitubercular Agents; D000637:Transaminases; D007538:Isoniazid; D008727:Methotrexate